| Secondary |
| Product Used For Unknown Indication |
33.3% |
| Drug Use For Unknown Indication |
16.7% |
| Drug Exposure During Pregnancy |
14.0% |
| Hiv Infection |
12.7% |
| Orthostatic Hypotension |
5.3% |
| Pain |
4.7% |
| Parkinson's Disease |
2.7% |
| Bronchiectasis |
1.3% |
| Colon Cancer |
1.3% |
| Hypotension |
1.3% |
| Anxiety |
0.7% |
| Bone Pain |
0.7% |
| Drug Toxicity |
0.7% |
| Dysthymic Disorder |
0.7% |
| General Symptom |
0.7% |
| Metastases To Bone |
0.7% |
| Neoplasm Prostate |
0.7% |
| Psychotic Disorder |
0.7% |
| Rash |
0.7% |
| Sleep Disorder |
0.7% |
|
| Hydrocephalus |
18.2% |
| Abortion Induced |
9.1% |
| Lip Oedema |
9.1% |
| Faecaloma |
6.1% |
| Inappropriate Antidiuretic Hormone Secretion |
6.1% |
| Sepsis |
6.1% |
| Somnolence |
6.1% |
| Bradycardia |
3.0% |
| Drug Exposure During Pregnancy |
3.0% |
| Gastrointestinal Disorder |
3.0% |
| Maternal Drugs Affecting Foetus |
3.0% |
| Neutropenia |
3.0% |
| Parotitis |
3.0% |
| Purpura |
3.0% |
| Pyrexia |
3.0% |
| Reversible Ischaemic Neurological Deficit |
3.0% |
| Self Injurious Behaviour |
3.0% |
| Synostosis |
3.0% |
| Ultrasound Scan |
3.0% |
| Urinary Retention |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
34.7% |
| Drug Use For Unknown Indication |
13.2% |
| Parkinson's Disease |
7.4% |
| Depression |
7.1% |
| Hypotension |
5.5% |
| Anxiety |
4.5% |
| Orthostatic Hypotension |
3.5% |
| Back Pain |
2.9% |
| Pain |
2.9% |
| Arthralgia |
2.3% |
| Urinary Tract Infection |
2.3% |
| Multiple Myeloma |
1.9% |
| Relapsing-remitting Multiple Sclerosis |
1.9% |
| Staphylococcal Sepsis |
1.9% |
| Prophylaxis |
1.6% |
| Atrial Fibrillation |
1.3% |
| Constipation |
1.3% |
| Haemosiderosis |
1.3% |
| Hodgkin's Disease |
1.3% |
| Hypertension |
1.3% |
|
| Vomiting |
16.1% |
| Somnolence |
8.9% |
| Bradycardia |
5.4% |
| Condition Aggravated |
5.4% |
| Overdose |
5.4% |
| Rebound Effect |
5.4% |
| Vertigo |
5.4% |
| Visual Impairment |
5.4% |
| Agranulocytosis |
3.6% |
| Confusional State |
3.6% |
| Delusion |
3.6% |
| General Physical Health Deterioration |
3.6% |
| Hallucination, Visual |
3.6% |
| Hepatitis |
3.6% |
| Hyponatraemia |
3.6% |
| Intentional Drug Misuse |
3.6% |
| Melaena |
3.6% |
| Nausea |
3.6% |
| Neutropenia |
3.6% |
| Off Label Use |
3.6% |
|
